SentinelOne (S) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CRISPR Therapeutics (CRSP) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

The prospects of the Zacks Mining - Non Ferrous industry appear promising at the moment, backed by the upward trajectory in ...

NGG is a solid investment pick due to its earnings growth projections, systematic capital expenditure plan and large-scale renewable energy projects.

Investors might want to bet on MercadoLibre (MELI), as earnings estimates for this company have been showing solid ...

FuelCell Energy came out with a quarterly loss of $1.79 per share versus the Zacks Consensus Estimate of a loss of $1.51. This compares to loss of $2.10 per share a year ago. These figures are ...

INDIANAPOLIS (AP) — INDIANAPOLIS (AP) — Hurco Cos. (HURC) on Friday reported a loss of $4.1 million in its fiscal second quarter. The Indianapolis-based company said it had a loss of 62 cents per ...

DANBURY, Conn. (AP) — DANBURY, Conn. (AP) — FuelCell Energy Inc. (FCEL) on Friday reported a loss of $38 million in its fiscal second quarter. On a per-share basis, the Danbury, Connecticut-based ...

(ABM) on Friday reported fiscal second-quarter profit of $42.2 million. On a per-share basis, the New York-based company said it had net income ...